OpenAlex
PricingAboutJobs
Log inGet started
Work

Late Breaking Abstract - Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma

HTML

Year: 2021
Type: conference-abstract
Source: European Respiratory Journal
DOI: 10.1183/13993003.congress-2021.pa890
Authors: Glenn Van Hulst, Joseph Jorssen, Nathalie Jacobs, Monique Henket, Renaud Louis, Florence Schleich, Fabrice Bureau, Christophe Desmet
Institutions: University of Liège, Centre Hospitalier Universitaire de Liège
Language: English

Topic: Asthma and respiratory diseases
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: mepolizumab, anti-IL-5 therapy, eosinophilic asthma, IL-5, IL-33, eosinophil activation, eosinophil development, omalizumab, eosinophilia
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3214737010
Cites:
Cited by: 3
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security